6 Covid Vaccines Undergoing Clinical Trials In India: Centre And Other Top Stories

6 Covid Vaccines Undergoing Clinical Trials In India: Centre And Other Top Stories

Covid-19 News | 6 Covid Vaccines Under Clinical Trials In India: GovernmentПодробнее

Covid-19 News | 6 Covid Vaccines Under Clinical Trials In India: Government

6 Covid Vaccines Undergoing Clinical Trials In India: CentreПодробнее

6 Covid Vaccines Undergoing Clinical Trials In India: Centre

6 vaccines undergoing clinical trials in India: NITI Aayog MemberПодробнее

6 vaccines undergoing clinical trials in India: NITI Aayog Member

COVID vaccines in India: 6 in different trial stages, 3 may get licensed in 'next few weeks'Подробнее

COVID vaccines in India: 6 in different trial stages, 3 may get licensed in 'next few weeks'

6 COVID vaccine candidates in clinical trial stage: Health MinistryПодробнее

6 COVID vaccine candidates in clinical trial stage: Health Ministry

Human trials begin across 6 Indian cities as race to find COVID-19 vaccine continuesПодробнее

Human trials begin across 6 Indian cities as race to find COVID-19 vaccine continues

Clinical Trials Of Russian Anti-Covid Vaccine To Begin In India This Month: OfficialПодробнее

Clinical Trials Of Russian Anti-Covid Vaccine To Begin In India This Month: Official

Covaxin under trail for Children | Vaccination | Covid-19 | Pandemic | International NewsПодробнее

Covaxin under trail for Children | Vaccination | Covid-19 | Pandemic | International News

New study finds rare side effects from COVID-19 vaccine 💉 #Health #Vaccines #COVID19Подробнее

New study finds rare side effects from COVID-19 vaccine 💉 #Health #Vaccines #COVID19

Covaxin Found To Be 77.8% Effective Against Covid And Other Top Stories | Good Morning IndiaПодробнее

Covaxin Found To Be 77.8% Effective Against Covid And Other Top Stories | Good Morning India

Second made-in-India COVID vaccine: Centre seals deal with Biological-E for 30 crore dosesПодробнее

Second made-in-India COVID vaccine: Centre seals deal with Biological-E for 30 crore doses

Centre Books 30 Crore Covid Vaccines From Biological- E For Rs.1500 Crore | Breaking NewsПодробнее

Centre Books 30 Crore Covid Vaccines From Biological- E For Rs.1500 Crore | Breaking News

Covid-19 Vaccine: Novavax Announces 90% Efficacy, Other Top Stories | Good Morning IndiaПодробнее

Covid-19 Vaccine: Novavax Announces 90% Efficacy, Other Top Stories | Good Morning India

Vaccine Shortage: Does India Have Enough Covid Vaccines? India Today-CII roundtable on NewstrackПодробнее

Vaccine Shortage: Does India Have Enough Covid Vaccines? India Today-CII roundtable on Newstrack

J&J's single-dose vaccine trial in India? | Covid-19 | India Second Wave | CoronavirusПодробнее

J&J's single-dose vaccine trial in India? | Covid-19 | India Second Wave | Coronavirus

India’s first covid vaccine candidate Covaxin approved for human trialsПодробнее

India’s first covid vaccine candidate Covaxin approved for human trials

Big Boost To India's COVID-19 Vaccination Programme, Here Are 5 Good NewsПодробнее

Big Boost To India's COVID-19 Vaccination Programme, Here Are 5 Good News

Biological-E Vaccine | Centre Reserves 30 Crore Doses Of Second Made-In-India Covid-19 VaccineПодробнее

Biological-E Vaccine | Centre Reserves 30 Crore Doses Of Second Made-In-India Covid-19 Vaccine

Biological- E Covid Vaccine Set To Become 3rd 'Made In India' VaccineПодробнее

Biological- E Covid Vaccine Set To Become 3rd 'Made In India' Vaccine

Актуальное